BOLD - Audentes Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.77B
Enterprise Value 31.43B
Trailing P/E N/A
Forward P/E 1-10.42
PEG Ratio (5 yr expected) 1-0.64
Price/Sales (ttm)N/A
Price/Book (mrq)4.35
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-9.28

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.12%
Return on Equity (ttm)-40.47%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -153.6M
Net Income Avi to Common (ttm)-152.64M
Diluted EPS (ttm)-3.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)369.5M
Total Cash Per Share (mrq)8.34
Total Debt (mrq)26.29M
Total Debt/Equity (mrq)6.54
Current Ratio (mrq)14.30
Book Value Per Share (mrq)9.19

Cash Flow Statement

Operating Cash Flow (ttm)-125.61M
Levered Free Cash Flow (ttm)-79.65M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.80
52-Week Change 3-6.68%
S&P500 52-Week Change 35.44%
52 Week High 346.18
52 Week Low 317.95
50-Day Moving Average 337.80
200-Day Moving Average 331.69

Share Statistics

Avg Vol (3 month) 3558.71k
Avg Vol (10 day) 3465.79k
Shares Outstanding 544.29M
Float 40.84M
% Held by Insiders 17.46%
% Held by Institutions 1103.43%
Shares Short (May 31, 2019) 41.79M
Short Ratio (May 31, 2019) 42.62
Short % of Float (May 31, 2019) 44.18%
Short % of Shares Outstanding (May 31, 2019) 44.05%
Shares Short (prior month Apr 30, 2019) 42.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A